US Patent Issued to Actinium Pharmaceuticals on April 21 for "Radiolabeling of anti-CD45 immunoglobulin and methods of use thereof" (New York, New Jersey Inventors)

ALEXANDRIA, Va., April 21 -- United States Patent no. 12,605,472, issued on April 21, was assigned to Actinium Pharmaceuticals Inc. (New York).

"Radiolabeling of anti-CD45 immunoglobulin and methods of use thereof" was invented by Dale Ludwig (Rockaway, N.J.) and Sandesh Seth (New York).

According to the abstract* released by the U.S. Patent & Trademark Office: "Compositions and methods useful for the treatment of hemoglobinopathies and hematological diseases are disclosed herein. The compositions include an actinium-225 labeled anti-CD45 antibody (BC8) formulated as a single patient dose that is wholly deliverable to a patient in a single dose. The actinium-225 labeled anti-CD45 may be administered alone or in combination with additional...